Regulatory SNP in the RBP4 gene modified the expression in adipocytes and associated with BMI

Obesity

Volumn 18, Issue 5, 2010, Pages 1006-1014

  Munkhtulga, Lkhagvasuren ^a,b   Nagashima, Shuichi ^a   Nakayama, Kazuhiro ^a   Utsumi, Nanami ^a   Yanagisawa, Yoshiko ^a,c   Gotoh, Takaya ^a   Omi, Toshinori ^a   Kumada, Maki ^a   Zolzaya, Khadbaatar ^b   Lkhagvasuren, Tserenkhuu ^b   Kagawa, Yasuo ^c   Fujiwara, Hiroyuki ^a   Hosoya, Yoshinori ^a   Hyodo, Masanobu ^a   Horie, Hisanaga ^a   Kojima, Masayuki ^a   Ishibashi, Shun ^a   Iwamoto, Sadahiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b MONGOLIAN NATIONAL UNIVERSITY OF MEDICAL SCIENCES   (Mongolia)

^c KAGAWA NUTRITION UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; PIOGLITAZONE; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ADIPOCYTE; ADULT; ALLELE; ARTICLE; ASIAN; BODY MASS; CELL CULTURE; CELL LINE; CHI SQUARE DISTRIBUTION; CYTOLOGY; DRUG EFFECT; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; PATIENT SELECTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOCYTES; ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CELL LINE; CELLS, CULTURED; CHI-SQUARE DISTRIBUTION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; MALE; PATIENT SELECTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RETINOL-BINDING PROTEINS, PLASMA; THIAZOLIDINEDIONES;

BOS; RATTUS;

EID: 77951666374     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.358     Document Type: Article

References (36)

1. Yang Q, Graham TE, Mody N et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362.
2. Shepherd PR, Kahn BB. Glucose transporters and insulin action\implications for insulin resistance and diabetes mellitus. N Engl J Med 1999;341:248-257.
3. Graham TE, Yang Q, Blüher M et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563.
4. Cho YM, Youn BS, Lee H et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006;29:2457-2461.
5. Balagopal P, Graham TE, Kahn BB et al. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007;92:1971-1974.
6. Broch M, Vendrell J, Ricart W, Richart C, Fernández-Real JM. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care 2007;30:1802-1806. (Pubitemid 47036355)
7. Stefan N, Hennige AM, Staiger H et al. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 2007;30:1173-1178.
8. Klöting N, Graham TE, Berndt J et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007;6:79-87.
9. Janke J, Engeli S, Boschmann M et al. Retinol-binding protein 4 in human obesity. Diabetes 2006;55:2805-2810.
10. Vitkova M, Klimcakova E, Kovacikova M et al. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J Clin Endocrinol Metab 2007;92:2330-2335.
11. Qi Q, Yu Z, Ye X et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 2007;92:4827-4834.
12. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007;92:2712-2719.
13. Jia W, Wu H, Bao Y et al. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 2007;92:3224-3229.
14. Yao-Borengasser A, Varma V, Bodles AM et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 2007;92:2590-2597.
15. Villarroya F, Iglesias R, Giralt M. Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes. Curr Med Chem 2004;11:795-805.
16. Ziouzenkova O, Orasanu G, Sharlach M et al. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 2007;13:695-702.
17. Munkhtulga L, Nakayama K, Utsumi N et al. Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Hum Genet 2007;120:879-888.
18. Kovacs P, Geyer M, Berndt J et al. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes 2007;56:3095-3100.
19. Haider DG, Schindler K, Prager G et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 2007;92:1168-1171.
20. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 1964;239:375-380.
21. Miyake S, Makimura M, Kanegae Y et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996;93:1320-1324.
22. Eloit M, Adam M. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species. J Gen Virol 1995;76:1583-1589.
23. Colantuoni V, Pirozzi A, Blance C, Cortese R. Negative control of liver-specific gene expression: cloned human retinol-binding protein gene is repressed in HeLa cells. EMBO J 1987;6:631-636.
24. Mercader J, Ribot J, Murano I et al. Remodeling of white adipose tissue after retinoic acid administration in mice. Endocrinology 2006;147: 5325-5332.
25. D'Onofrio C, Colantuoni V, Cortese R. Structure and cell-specific expression of a cloned human retinol binding protein gene: the 5'-flanking region contains hepatoma specific transcriptional signals. EMBO J 1985;4:1981-1989.
26. Panariello L, Quadro L, Trematerra S, Colantuoni V. Identification of a novel retinoic acid response element in the promoter region of the retinol-binding protein gene. J Biol Chem 1996;271:25524-25532.
27. Mercader J, Granados N, Bonet ML, Palou A. All-trans retinoic acid decreases murine adipose retinol binding protein 4 production. Cell Physiol Biochem 2008;22:363-372.
28. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.
29. Ost A, Danielsson A, Lidén M et al. Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J 2007;21:3696-3704.
30. Sell H, Eckel J. Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-alpha. Diabetologia 2007;50:2221-2223.
31. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004;117:421-426.
32. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998;78:783-809.
33. Jessen KA, Satre MA. Induction of mouse retinol binding protein gene expression by cyclic AMP in Hepa 1-6 cells. Arch Biochem Biophys 1998;357:126-130.
34. Yang X, Jansson PA, Nagaev I et al. Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun 2004;317:1045-1051.
35. Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996;10:1096-1107.
36. Tang QQ, Grønborg M, Huang H et al. Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proc Natl Acad Sci USA 2005;102:9766-9771.